本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

COLLPLANT BIOTECHNOLOGIES LTD

2.02
-0.1200-5.61%
成交量:5,521.00
成交額:1.15萬
市值:2,568.63萬
市盈率:-1.79
高:2.11
開:2.10
低:2.02
收:2.14
52周最高:4.98
52周最低:1.31
股本:1,271.60萬
流通股本:891.32萬
量比:0.58
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-1.1257
每股收益(LYR):-1.4500
淨資產收益率:-78.25%
總資產收益率:-37.90%
市淨率:2.05
市盈率(LYR):-1.39

資料載入中...

2025/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

SEC問詢函

Form CORRESP - Correspondence
2025/06/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/03/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/24

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans